Mobility paves Samsung’s silver path
The Korean giant’s early bet on mobile phones helped it hit the $10-bn mark in India, but in its 25th year it ...
Soon, a simple, inexpensive blood test could be all that is required to reliably detect and diagnose cancer, even before any symptoms appear.
A team of scientists from India, the US and the UK have developed a novel method to detect clusters of cancer cells in the blood through a simple test. The clinical evidence for this ‘innovative’ test has been published by the scientists.
“This is the first study of its kind to investigate the prevalence of circulating tumour emboli, or C-ETACs (Circulating Ensembles of Tumor Associated Cells), in over 16,000 participants, to establish the definitive new systemic hallmark of cancer,” Dadasaheb Akolkar, the principal author of the study and Research Director at Datar Cancer Genetics, said in a release.
Rajan Datar, Chairman and Managing Director, Datar Cancer Genetics, said: “Cancer deaths are mainly because of late detection. We believe that this innovative blood-based test is a breakthrough in cancer screening and will impact outcomes through easy, patient-friendly detection and diagnosis in apparently healthy people who may have a silent malignancy in their bodies.” It has the potential to eliminate the need for invasive biopsies and the risks associated with it, he added.
The study involved 16,134 participants, including 5,509 with cancer (TrueBlood study) and 10,625 with no symptoms (Resolute study). The test showed an accuracy of more than 94 per cent. The C-ETACs were seen in 89.8 per cent of the cancer cases and in only 3 per cent of the apparently healthy, asymptomatic individuals who had no abnormal findings in presently used screening tests.
Speaking to BusinessLine, Vineet Datta, Executive Director, Datar Cancer Genetics, said the test could be used to detect all major variants of cancer including of the breast and the lung. It is likely to be available commercially soon.
The Korean giant’s early bet on mobile phones helped it hit the $10-bn mark in India, but in its 25th year it ...
Antrix should adopt a different tactic than merely fighting over jurisdiction: Experts
Invest in relationships, enterprise, behaviour, effort and learning
From different types of osmoses to new membranes, researchers have come up with ways of drawing water
High valuation and stiff competition from larger players are a dampener
Will a stock continue its current trend or will it reverse? We tell you how you can read chart patterns to ...
Most AMCs have been sending out cryptic e-mails. We tell you how to read between the lines
Slew of factors are building a good foundation for the bulls to work their way up
In these isolated times when people yearn for a slice of the familiar, amateur and professional chefs are ...
‘You ready to go to work?’ Joe Biden had asked Kamala Harris before naming her as his running mate. ‘Oh my ...
Writer Narendra’s latest book, rich with vignettes from Bastar and his native village in Uttar Pradesh, ...
On the eve of his 86th birthday, a peek into an interview-based book that reveals the actor’s many moods, ...
Digital is becoming dominant media, but are companies and their ad agencies transforming fast enough to make a ...
Slow Network, promoted by journalist-lyricist Neelesh Misra, pushes rural products and experiences
How marketers can use the traditional exchange of festive wishes meaningfully
For Fortune, a brand celebrating its 20th anniversary, it was a rude shock to become the butt of social media ...
Three years after its inception, compliance with GST procedures remains a headache for exporters, job workers ...
Corporate social responsibility (CSR) initiatives of companies are altering the prospects for wooden toys of ...
Aequs Aerospace to create space for large-scale manufacture of toys at Koppal
And it has every reason to smile. Covid-19 has triggered a consumer shift towards branded products as ...
Please Email the Editor